Yves Allory

14PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 04, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancer.

Yohann Loriot, Maud Kamal, Laurene Syx

|Jul 29, 2024
Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.

Zakhia El Beaino, Célia Dupain, Grégoire Marret

|Jul 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.

Nicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon

|Dec 28, 2023
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.

Yves Allory, Stephane Culine, Clémentine Krucker

|Mar 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Stéphane Culine, Valentin Harter, Clémentine Krucker

|Jan 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis.

Jacqueline Fontugne, Jennifer Wong, Luc Cabel

Pageof 3

Frequent Collaborators

4 joint publications

Maud Kamal

3 joint publications

Nicolas Servant

3 joint publications

Jean-Yves Scoazec

3 joint publications

Christian Pfister